101 related articles for article (PubMed ID: 19660777)
1. [Mechanisms of deregulated response to hypoxia in sporadic amyotrophic lateral sclerosis: a clinical study].
Moreau C; Devos D; Gosset P; Brunaud-Danel V; Tonnel AB; Lassalle P; Defebvre L; Destée A
Rev Neurol (Paris); 2010 Mar; 166(3):279-83. PubMed ID: 19660777
[TBL] [Abstract][Full Text] [Related]
2. CSF profiles of angiogenic and inflammatory factors depend on the respiratory status of ALS patients.
Moreau C; Gosset P; Brunaud-Danel V; Lassalle P; Degonne B; Destee A; Defebvre L; Devos D
Amyotroph Lateral Scler; 2009 Jun; 10(3):175-81. PubMed ID: 19177252
[TBL] [Abstract][Full Text] [Related]
3. Deregulation of the hypoxia inducible factor-1α pathway in monocytes from sporadic amyotrophic lateral sclerosis patients.
Moreau C; Gosset P; Kluza J; Brunaud-Danel V; Lassalle P; Marchetti P; Defebvre L; Destée A; Devos D
Neuroscience; 2011 Jan; 172():110-7. PubMed ID: 20977930
[TBL] [Abstract][Full Text] [Related]
4. High erythropoietin and low vascular endothelial growth factor levels in cerebrospinal fluid from hypoxemic ALS patients suggest an abnormal response to hypoxia.
Just N; Moreau C; Lassalle P; Gosset P; Perez T; Brunaud-Danel V; Wallaert B; Destée A; Defebvre L; Tonnel AB; Devos D
Neuromuscul Disord; 2007 Feb; 17(2):169-73. PubMed ID: 17142042
[TBL] [Abstract][Full Text] [Related]
5. Etiogenic factors present in the cerebrospinal fluid from amyotrophic lateral sclerosis patients induce predominantly pro-inflammatory responses in microglia.
Mishra PS; Vijayalakshmi K; Nalini A; Sathyaprabha TN; Kramer BW; Alladi PA; Raju TR
J Neuroinflammation; 2017 Dec; 14(1):251. PubMed ID: 29246232
[TBL] [Abstract][Full Text] [Related]
6. Astroglia acquires a toxic neuroinflammatory role in response to the cerebrospinal fluid from amyotrophic lateral sclerosis patients.
Mishra PS; Dhull DK; Nalini A; Vijayalakshmi K; Sathyaprabha TN; Alladi PA; Raju TR
J Neuroinflammation; 2016 Aug; 13(1):212. PubMed ID: 27578023
[TBL] [Abstract][Full Text] [Related]
7. Elevated IL-6 and TNF-alpha levels in patients with ALS: inflammation or hypoxia?
Moreau C; Devos D; Brunaud-Danel V; Defebvre L; Perez T; Destée A; Tonnel AB; Lassalle P; Just N
Neurology; 2005 Dec; 65(12):1958-60. PubMed ID: 16380619
[TBL] [Abstract][Full Text] [Related]
8. Erythropoietin and amyotrophic lateral sclerosis: Plasma level determination.
Carilho R; de Carvalho M; Kuehl U; Pinto S; Pinto A; Kromminga A; Costa J
Amyotroph Lateral Scler; 2011 Nov; 12(6):439-43. PubMed ID: 21722017
[TBL] [Abstract][Full Text] [Related]
9. Vascular endothelial growth factor attenuates neurodegenerative changes in the NSC-34 motor neuron cell line induced by cerebrospinal fluid of sporadic amyotrophic lateral sclerosis patients.
Kulshreshtha D; Vijayalakshmi K; Alladi PA; Sathyaprabha TN; Nalini A; Raju TR
Neurodegener Dis; 2011; 8(5):322-30. PubMed ID: 21389676
[TBL] [Abstract][Full Text] [Related]
10. Cerebrospinal fluid angiogenin level in patients with amyotrophic lateral sclerosis.
Iłzecka J
Acta Clin Croat; 2008 Jun; 47(2):77-9. PubMed ID: 18949901
[TBL] [Abstract][Full Text] [Related]
11. Cerebrospinal fluid erythropoietin (EPO) in amyotrophic lateral sclerosis.
Brettschneider J; Widl K; Schattauer D; Ludolph AC; Tumani H
Neurosci Lett; 2007 Apr; 416(3):257-60. PubMed ID: 17368721
[TBL] [Abstract][Full Text] [Related]
12. Angiogenin protects motoneurons against hypoxic injury.
Sebastià J; Kieran D; Breen B; King MA; Netteland DF; Joyce D; Fitzpatrick SF; Taylor CT; Prehn JH
Cell Death Differ; 2009 Sep; 16(9):1238-47. PubMed ID: 19444281
[TBL] [Abstract][Full Text] [Related]
13. Intrathecal upregulation of granulocyte colony stimulating factor and its neuroprotective actions on motor neurons in amyotrophic lateral sclerosis.
Tanaka M; Kikuchi H; Ishizu T; Minohara M; Osoegawa M; Motomura K; Tateishi T; Ohyagi Y; Kira J
J Neuropathol Exp Neurol; 2006 Aug; 65(8):816-25. PubMed ID: 16896315
[TBL] [Abstract][Full Text] [Related]
14. VEGF levels in CSF and serum in mild ALS patients.
Gao L; Zhou S; Cai H; Gong Z; Zang D
J Neurol Sci; 2014 Nov; 346(1-2):216-20. PubMed ID: 25204587
[TBL] [Abstract][Full Text] [Related]
15. Cerebrospinal fluid vascular endothelial growth factor in patients with amyotrophic lateral sclerosis.
Iłzecka J
Clin Neurol Neurosurg; 2004 Sep; 106(4):289-93. PubMed ID: 15297002
[TBL] [Abstract][Full Text] [Related]
16. [Inflammatory mechanisms in amyotrophic lateral sclerosis].
Fujita K; Izumi Y; Kaji R
Brain Nerve; 2012 Mar; 64(3):273-8. PubMed ID: 22402721
[TBL] [Abstract][Full Text] [Related]
17. [Hypoxia/reoxygenation and lipopolysaccharide induced nuclear factor-ΚB and hypoxia-inducible factor-1α signaling pathways in intestinal epithelial cell injury and the interventional effect of emodin].
Qi L; Yuan B; Fu Q
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 Jun; 26(6):409-14. PubMed ID: 24912640
[TBL] [Abstract][Full Text] [Related]
18. Elevated serum angiogenin levels in ALS.
Cronin S; Greenway MJ; Ennis S; Kieran D; Green A; Prehn JH; Hardiman O
Neurology; 2006 Nov; 67(10):1833-6. PubMed ID: 17130418
[TBL] [Abstract][Full Text] [Related]
19. A CSF biomarker panel for identification of patients with amyotrophic lateral sclerosis.
Mitchell RM; Freeman WM; Randazzo WT; Stephens HE; Beard JL; Simmons Z; Connor JR
Neurology; 2009 Jan; 72(1):14-9. PubMed ID: 18987350
[TBL] [Abstract][Full Text] [Related]
20. Job strain, hypoxia and risk of amyotrophic lateral sclerosis: Results from a death certificate study.
Vanacore N; Cocco P; Fadda D; Dosemeci M
Amyotroph Lateral Scler; 2010 Oct; 11(5):430-4. PubMed ID: 20698805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]